ARMISTICE CAPITAL LLC 13D and 13G filings for AIM IMMUNOTECH INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:55 pm Sale | 2024-12-31 | 13G | AIM IMMUNOTECH INC AIMI | ARMISTICE CAPITAL LLC | 3,349,740 4.990% | -980,260 (-22.64%) | Filing |
| 2024-11-14 3:21 pm Purchase | 2024-09-30 | 13G | AIM IMMUNOTECH INC AIMI | ARMISTICE CAPITAL LLC | 4,330,000 6.840% | 4,330,000 (New Position) | Filing |